Patent pool for HIV medicines

According to Businessweek:

“Gilead Sciences Inc., Merck & Co. and Johnson & Johnson are in talks to license their patented AIDS treatments to generic-drug makers in developing nations”

Licences will be made available through a patent pool which will:

“…allow makers of copycat pills to market the drugs in poorer nations… the initiative would be the first pool for HIV medicines”

For more information visit

(Thanks to Victoria Henson-Apollonio for the link)


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s